Eloxx Pharmaceuticals, Inc. (ELOX) — SC 13D/A Filings
All SC 13D/A filings from Eloxx Pharmaceuticals, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Advent Life Sciences Amends Eloxx Pharma Stake
— Aug 20, 2024 Risk: medium
Advent Life Sciences Fund II LP, along with Dominic Schmidt, Kaasim Mahmood, Rajesh Parekh, and Shahzad Malik, filed an amendment (SC 13D/A) on August 20, 2024,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX